Cite
THE ROLE OF ORAL BETA BLOCKER IN A REAL-WORLD POPULATION WITH NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES.
MLA
Nicolau, Jose C., et al. “The Role of Oral Beta Blocker in a Real-World Population with Non-St Segment Elevation Acute Coronary Syndromes.” Journal of the American College of Cardiology (JACC), vol. 69, Mar. 2017, p. 106. EBSCOhost, https://doi.org/10.1016/S0735-1097(17)33495-2.
APA
Nicolau, J. C., Ferrari, A., Coelho, G. M. M., Nakashima, C. A. K., Lima, V. M., Dalcoquio, T., Furtado, R., Menezes, F., Ramires, J., Kalil-Filho, R., & Baracioli, L. (2017). The Role of Oral Beta Blocker in a Real-World Population with Non-St Segment Elevation Acute Coronary Syndromes. Journal of the American College of Cardiology (JACC), 69, 106. https://doi.org/10.1016/S0735-1097(17)33495-2
Chicago
Nicolau, Jose C., Aline Ferrari, Gabriela M.M. Coelho, Carlos A.K. Nakashima, Viviane M. Lima, Talia Dalcoquio, Remo Furtado, et al. 2017. “The Role of Oral Beta Blocker in a Real-World Population with Non-St Segment Elevation Acute Coronary Syndromes.” Journal of the American College of Cardiology (JACC) 69 (March): 106. doi:10.1016/S0735-1097(17)33495-2.